Our study proved that H. pylori CagA induces mitochondrial oxidative damage, mitochondrial dysfunction, dynamic imbalance, mitophagy, and autophagy flux blockage in infected cells. Mitophagy activation attenuates NLRP3 inflammasome activation caused by H. pylori infection and enhances the survival and viability of infected cells. This suggests that mitophagy activated by H. pylori CagA may be an adaptive response of cells to escape host immune surveillance against H. pylori infection. Additionally, autophagy flux blockage causes an accumulation of dysfunctional mitochondria, which may involve in the tumorigenesis caused by H. pylori infection.
Mitochondria continue the normal physiological activities of the cell as an essential energy source generator to maintain cell homeostasis only when their morphology and function are normal. Virulence factors secreted by bacteria may interact with mitochondria as a part of a key strategy for hijacking host cell physiology and promoting infection[24]. H. pylori is a pathogen that affects the human gastric mucosa and is a major contributor to the development of gastric cancer; it has been reported to damage mucosal epithelial cells and target mitochondria, decrease the activity of oxidative phosphorylation and electron transport chain, and cause mitochondrial dysfunction and apoptosis[25]. To date, the vacuolating cytotoxin A (VacA) is the only H. pylori protein reported to target mitochondria and decrease mitochondrial membrane potential, reducing ATP production and cytochrome c release [26]. Although CagA is an important virulence factor of H. pylori, its role in inducing mitochondrial function injury remains elusive. In this study, we infected AGS and GES-1 cells with GZ7/CagA and GZ7/ΔCagA strains, respectively, followed by the detection of mitochondrial membrane potential, ATP production, cell apoptosis, and mitochondrial fusion division. Results revealed that H. pylori infection reduced mitochondrial membrane potential and ATP production levels, promoted cell apoptosis, decreased the expression of mitochondrial fusion-related proteins Mfn1 and Mfn2, and increased the expression of mitochondrial fission-related proteins Drp1 and Fis1. In these processes, the results of the GZ7/CagA-infected group were more significant. It was further confirmed that H. pylori can induce mitochondrial dysfunction, mitochondrial dynamic imbalance, and apoptosis of infected cells, and CagA plays an important role in these processes.
Damaged mitochondria can induce mitophagy as a defense mechanism to eliminate damaged mitochondria and over-produced ROS, ensure the maintenance of mitochondrial homeostasis, and promote cell survival in stressful environments[27]. Mitophagy is widely regarded as a major regulatory mechanism of mitochondrial quality control processes and is involved in the regulation of host immune responses[28]. Previous research has suggested that H. pylori can induce defective autophagy or inhibit autophagy, allowing H. pylori to proliferate[29]. The VacA produced by H. pylori specifically targets mitochondria, destroys mitochondrial membrane potential, causes mitochondrial damage, and induces mitophagy[30]. Furthermore, research suggests that CagA can inhibit autophagy via the mesenchymal-epithelial transition factor-phosphatidylinositol 3-kinase/protein kinase B-mechanistic target of the Rapamycin signaling pathway[31]. However, CagA-induced mitochondrial damage and its effect on mitophagy remain unclear. In our study, we observed little bleeding and inflammatory cell infiltration in the submucosa of the gastric tissue from GZ7/CagA-infected C57bl/6 mice in vivo, indicating an inflammatory response in the gastric mucosa of H. pylori-infected mice. Furthermore, we discovered that the expression of mitophagy-related proteins P62, LC3, PINK1, and Parkin increased significantly in the gastric mucosal tissue of GZ7/cagA-infected mice. Consistent with that in H. pylori-infected mice in vivo, the mitophagy-related proteins PINK1, Parkin, P62, LC3, VDAC1, and TOM20 expression increased significantly in H. pylori-infected cells in vitro. Immunofluorescence staining revealed that H. pylori-infected cells dispersed LC3 in the cytoplasm and exhibited increased expression as an indicator of mitophagy. Additionally, an accumulation of autophagosomes and autolysosomes in H. pylori-infected cells was detected by TEM. Furthermore, the autophagic flux observed using confocal microscopy revealed that H. pylori infection enhanced the level of mitophagy in infected cells, albeit the fusion of autophagosome and lysosome was limited. In these processes, the results of GZ7/GZ7/cagA-infected cells were more significant. Although autophagy can limit exogenous infections, it has been reported that bacterial pathogens have evolved mechanisms to interfere with autophagy initiation or autophagy flux for their benefit[32]. Our results presented that H. pylori CagA promotes mitophagy induction but inhibits a specific stage of autophagosome maturation, causing blocked autophagy flux. Considering that the accumulation of dysfunctional mitochondria is involved in tumorigenesis, it may be one of the pathogenic mechanisms by which H. pylori and its CagA cause gastric cancer.
Mitophagy is important in limiting inflammasome activation to prevent mitochondrial damage and is used by viruses and bacteria to avoid host immune clearance[33]. Mitophagy, a crucial component in the preservation of mitochondrial homeostasis, develops through the elimination of damaged mitochondria, thereby, preventing hyperinflammation triggered by NLRP3 inflammasome activation and destruction of intracellular pathogens[34]. Similarly, the NLRP3 inflammasome signaling pathway can regulate autophagy and help maintain a balance between the necessary host defense inflammatory response and the prevention of excessive and harmful inflammation[35]. Recent studies have revealed that some pathogens can directly or indirectly trigger mitophagy and regulate the process of mitophagy via various strategies, thereby, weakening the innate immune response and allowing pathogens to promote persistent infection, which impacts the development of infectious diseases. Pseudomonas aeruginosa can disrupt mitochondrial homeostasis in host cells, thus, activating mitophagy, which enhances the host defense against the toxic responses caused by its virulence factor Pyoverdin[36]. Mycobacterium bovis (M. bovis) infection induces mitophagy in murine macrophages, and induction of mitophagy improves M. bovis growth, whereas inhibition of mitophagy improves growth restriction[37]. We infected AGS and GES-1 cells with GZ7/CagA and GZ7/ΔCagA strains combined with mitophagy inducer (Olaparib), mitophagy inhibitor (BafA1), and NLRP3 inflammasome inhibitor (MCC950), respectively. The results demonstrated that olaparib-stimulated mitophagy can inhibit the activation of NLRP3 inflammasomes induced by H. pylori CagA; inhibition of mitophagy by BafA1 may cause the over-activation of NLRP3 inflammasome in H. pylori-infected cells, whereas inhibition of NLRP3 inflammasome by MCC950 reduced mitophagy induced by H. pylori. Our results confirmed that H. pylori CagA promoted mitophagy and was involved in NLRP3 inflammasome activation against H. pylori infection, thereby, inhibiting the antibacterial innate immune response, which may enhance pathogen intracellular survival and cause persistent infections.
Mitophagy is important in cancer cell homeostasis and tumor progression, acting as a pro-cancer or anticancer factor, and its failure promotes oncogenic stress and tumorigenesis[38–40]. The normal level of mitophagy is the body's defense and protection mechanism against various environmental pressures; however, excessive abnormal mitophagy may cause an abnormal mitochondrial network and energy metabolism disorder, which leads to cancer occurrence and progression[41]. Although H. pylori is an extracellular pathogen, it can also survive intracellularly in GES, causing chronic infection and even the development of gastric cancer. The potential of mitophagy as a mechanism and therapeutic strategy remains elusive in this process. In our study, we confirmed that inhibition of mitophagy can increase the apoptosis rate and decrease the cell viability of H. pylori-infected cells, suggesting that CagA mediates H. pylori to induce mitophagy, which attenuated the activation of NLRP3 inflammasome to escape host immune surveillance and enhanced the survival and viability of infected cells from a contrasting perspective. It eventually causes chronic H. pylori infection and promotes the development of gastric cancer. Furthermore, mitophagy inhibition can be considered one of the new strategies for the prevention and treatment of H. pylori-caused gastric cancer.
In conclusion, our findings revealed that H. pylori causes mitochondrial oxidative damage, mitochondrial dysfunction, dynamic imbalance, mitophagy, and autophagy flux blockage primarily through its CagA. Mitophagy induction regulates the activation of the NLRP3 inflammasome, which may be one of the strategies of H. pylori for evading the immune response and enhancing the survival and viability of infected cells, potentially enhancing pathogen intracellular survival and causing persistent infections(Figure 10). The blockage of autophagy flux can cause the accumulation of dysfunctional mitochondria, which may play a role in tumorigenesis caused by H. pylori infection. Our findings improve our understanding of the pathogenesis of H. pylori-induced gastric cancer, and mitophagy inhibition can be one of the novel strategies for the prevention and treatment of H. pylori-induced gastric cancer.